We are live on ! Find out more
GP

GLR Partners Portfolio holdings

AUM $215M
This Fund
S&P 500
This Quarter Est. Return
-1.79%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
–
Cap. Flow
+$190M
Cap. Flow %
103.87%
Top 10 Hldgs %
46.34%
Holding
101
New
101
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.85%
2 Technology 10.57%
3 Healthcare 7.39%
4 Communication Services 6.39%
5 Industrials 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IBRX icon
101
ImmunityBio
IBRX
$10.5B
$153K 0.08%
+20,000
New +$137K
2026 Q1
0 quarters

Similar funds

GLR Partners's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for GLR Partners, which disclosed 101 positions worth $183M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Pacer US Cash Cows 100 ETF: 264,069 shares worth $16.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, followed by Technology and Healthcare.

  • GLR Partners's largest Q1 2026 buy was Pacer US Cash Cows 100 ETF: 264,069 shares worth $16.5M.
  • GLR Partners's ten largest holdings make up 46% of its $183M portfolio in Q1 2026.
  • GLR Partners disclosed 101 positions in Q1 2026, its first 13F filing on record.

Based on GLR Partners's 13F filing for Q1 2026, filed 13 May 2026.